Ginkgo Bioworks Holdings Inc vs Packaging Corporation of America — how do they compare? Ginkgo Bioworks Holdings Inc trades at $11.99 (market cap $763.64M), while Packaging Corporation of America trades at $231.22 (market cap $20.49B). The key difference: Packaging Corporation of America is far larger — about 26.8× Ginkgo Bioworks Holdings Inc's market cap, and Packaging Corporation of America pays a 2.61% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and Packaging Corporation of America for 45 Days on average.
| DNA | PKG | |
|---|---|---|
Market Cap | $763.64M | $20.49B |
Volume | 3,204,177 | 493,499 |
Sector | Health | Consumer Cyclical |
52-Week High | $15.83 | $257.43 |
52-Week Low | $5.48 | $191.68 |
Typical Hold Time | 7 Days | 45 Days |
Enterprise Value | $865.59M | $24.30B |
Dividend Yield | — | 2.61% |
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $11.47, down 7.57% today, reflecting ongoing volatility. The stock shows a bullish technical signal with strong moving average support, but fundamentals reveal significant challenges: revenue declined to $170.16M in 2025 with a net loss of $312.76M, and negative cash flow persists. Recent news includes a partnership with TuneLab for AI-driven drug discovery and a $17.5M ARPA-H subcontract for RNA medicine manufacturing, indicating strategic growth initiatives amid financial headwinds.
The outlook remains high-risk due to persistent losses and cash burn, though analyst sentiment is split evenly between buy, hold, and sell. Upside potential hinges on successful commercialization of its platform and cost management, while downside risks include execution missteps and prolonged profitability challenges. Investors should weigh the company's innovative partnerships against its weak financial metrics.
Packaging Corporation of America (PKG) trades at $227.25, down 1.08% on the day, amid a bearish technical signal. The stock shows mixed earnings performance, with Q2 2026 beating estimates but net income margin projected to decline in 2026. Analyst consensus is a Buy with a $272.43 price target, though technical indicators suggest near-term pressure with support at $225.
PKG offers a stable dividend and benefits from consistent packaging demand, but faces headwinds from cost pressures and negative cash flow. Investment appeal hinges on execution against margin challenges and the upcoming Q3 earnings report. Risks include rising input costs and competitive pressures in the industrial packaging sector.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →Packaging Corporation of America is a leading producer of containerboard and corrugated packaging products in North America. The company also produces white papers, which include printing and writing papers. PKG operates as an integrated manufacturer, with a strong focus on high-quality and sustainable packaging solutions for e-commerce, food and beverage, and other industrial and consumer markets.
Read more on PKG →